The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 12,101–12,200 of 31,469
Tsuchihashi, K., Hikita, N., Hase, M., et al. (1999) · Internal Medicine · doi:10.2169/internalmedicine.38.691 · Cited by 29
Faria, A. N., Filho, F. F. R., Kohlmann, N. E. B., Ferreira, S. R. G., & Zanella, M. T. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00465.x · Cited by 29
Shi, Y., Dong, B., Dong, Q., Zhao, Z., & Yu, Y. (2021) · Journal of PeriAnesthesia Nursing · doi:10.1016/j.jopan.2020.05.006 · Cited by 27
Bonnet, F., Velayoudom Cephise, F., Gautier, A., Dubois, S., Massart, C., Camara, A., Larifla, L., Balkau, B., & Ducluzeau, P. (2013) · Clinical Endocrinology · doi:10.1111/cen.12089 · Cited by 28
Costabile, G., Della Pepa, G., Salamone, D., Luongo, D., Naviglio, D., Brancato, V., Cavaliere, C., Salvatore, M., Cipriano, P., Vitale, M., et al. (2022) · Nutrients · doi:10.3390/nu14102178 · Cited by 27
“The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated using the following formula: fasting glucose (mg/dL) × fasting insulin (μU/mL)/405 [14].”
MethodBehan, L.-A., Carmody, D., Rogers, B., Hannon, M. J., Davenport, C., Tormey, W., Smith, D., Thompson, C. J., Stanton, A., & Agha, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1187 · Cited by 28
DE SOUSA, G., SCHLÜTER, B., MENKE, T., TROWITZSCH, E., ANDLER, W., & REINEHR, T. (2011) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2010.00902.x · Cited by 28
Russo, M. F., Lembo, E., Mari, A., Angelini, G., Verrastro, O., Nanni, G., Pompili, M., Raffaelli, M., Vecchio, F. M., Bornstein, S. R., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa892 · Cited by 28
Campbell, W. W., Kim, J. E., Amankwaah, A. F., Gordon, S. L., & Weinheimer-Haus, E. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.115.213595 · Cited by 28
Chee, C., Shannon, C. E., Burns, A., Selby, A. L., Wilkinson, D., Smith, K., Greenhaff, P. L., & Stephens, F. B. (2021) · Aging Cell · doi:10.1111/acel.13303 · Cited by 29
“Homeostatic model assessment of insulin resistance (HOMA-IR) was calculated by the equation of Matthews et al. (1985) using fasting glucose (G; mmol/L) and insulin (I; mU/L) concentrations ((G × I)/22.5).”
MethodInfluentialFerrari, D., Bonaventura, I., Simeoli, C., Tomaselli, A., Vincenzi, L., De Alcubierre, D., Sciarra, F., Rizzo, F., Cerroni, L., Di Paola, N., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf206 · Cited by 28
Asferg, C. L., Andersen, U. B., Linneberg, A., Goetze, J. P., & Jeppesen, J. L. (2014) · Diabetic Medicine · doi:10.1111/dme.12411 · Cited by 26
Cheong, J. N., Cuffe, J. S. M., Jefferies, A. J., Anevska, K., Moritz, K. M., & Wlodek, M. E. (2016) · Endocrinology · doi:10.1210/en.2016-1335 · Cited by 28
Exercise and Insulin Resistance in Youth
Shaibi, G. Q., Roberts, C. K., & Goran, M. I. (2008) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e31815e38c5 · Cited by 28
Yang, B., Shi, M.-Q., Li, Z.-H., Shi, L., Wang, A.-M., Guo, X.-J., & Li, D. (2019) · Food & Function · doi:10.1039/c8fo01707g · Cited by 28
Insulin Secretion and Resistance in Normoglycemic Patients with Sickle Cell Disease
Yavropoulou, M. P., Pikilidou, M. I., Pantelidou, D., Tsalikakis, D., Mousiolis, A. C., Chalkia, P., Yovos, J. G., & Zebekakis, P. E. (2017) · Hemoglobin · doi:10.1080/03630269.2017.1295983 · Cited by 28
Germano, C. W., Mega, P. F., Mattosinho, T. J. A. P., Dias, L. L. C., Gestic, M. A., Utrini, M. P., Chaim, F. D. M., Callejas-Neto, F., Chaim, É. A., & Cazzo, E. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06467-9 · Cited by 28
Feyzioğlu, B. S., Güven, C. M., & Avul, Z. (2023) · Nutrients · doi:10.3390/nu15102260 · Cited by 35
Fathy, M. A., Alsemeh, A. E., Habib, M. A., Abdelnour, H. M., Hendawy, D. M., Eltaweel, A. M., Abdelkhalek, A., Ahmed, M. M., Desouky, M. K., Hua, J., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1224985 · Cited by 33
Georgoulis, M., Damigou, E., Chrysohoou, C. A., Barkas, F., Anastasiou, G., Kravvariti, E., Tsioufis, C. P., Liberopoulos, E. N., Sfikakis, P. P., Pitsavos, C. S., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.09.019 · Cited by 28
Iglesies‐Grau, J., García‐Álvarez, A., Oliva, B., Mendieta, G., García‐Lunar, I., Fuster, J. J., Devesa, A., Pérez-Herreras, C., Fernández‐Ortíz, A., Brugada, R., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02090-1 · Cited by 29
Definition, Classification, Diagnosis and Differential Diagnosis of Diabetes Mellitus: Update 2023
Pleus, S., Tytko, A., Landgraf, R., Heinemann, L., Werner, C., Müller‐Wieland, D., Ziegler, A., Müller, U., Freckmann, G., Kleinwechter, H. J., et al. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2166-6643 · Cited by 37
Cinzori, M. E., Pacyga, D. C., Rosas, L., Whalen, J., Smith, S. C., Park, J.-S., Geiger, S. D., Gardiner, J. C., Braun, J. M., Schantz, S. L., et al. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118434 · Cited by 30
McLaren, J. B., Gao, X., Ghouri, N., Freeman, D. J., Richardson, J., Sattar, N. A., & Gill, J. M. R. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01101-z · Cited by 30
Elmorsy, E. A., Elsisi, H. A., Alkhamiss, A. S., Alsoqih, N. S., Khodeir, M. M., Alsalloom, A. A., Almeman, A. A., Elghandour, S. R., Nadwa, E. H., Khalifa, A. K., et al. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107002 · Cited by 32
The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD + Therapy in HFpEF
Koay, Y. C., McIntosh, B., Ng, Y. H., Cao, Y., Wang, X., Han, Y., Tomita, S., Bai, Y., Hunter, B., Misra, A., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.325550 · Cited by 33
Inoue, Y., Kawai, M., Minai, K., Ogawa, K., Nagoshi, T., Ogawa, T., & Yoshimura, M. (2015) · Metabolism · doi:10.1016/j.metabol.2015.09.019 · Cited by 28
Premanath, M., Basavanagowdappa, H., Mahesh, M., & Suresh, M. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.139231 · Cited by 29
Xanthine Oxidase and Cardiovascular Risk in Obese Children
Tam, H. K., Kelly, A. S., Metzig, A. M., Steinberger, J., & Johnson, L. A. (2014) · Childhood Obesity · doi:10.1089/chi.2013.0098 · Cited by 28
Ciresi, A., Amato, M. C., & Giordano, C. S. D. S. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0184-4 · Cited by 28
Early Decreases in Plasma Lipid Transfer Proteins During Weight Reduction
Tzotzas, T., Dumont, L., Triantos, A. A., Karamouzis, M., Constantinidis, T. C., & Lagrost, L. (2006) · Obesity · doi:10.1038/oby.2006.119 · Cited by 29
Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats
Victoriano, M., Hermier, D., Even, P. C., Fromentin, G., Huneau, J., Tomé, D., & de Beaurepaire, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1593-5 · Cited by 28
Shigematsu, Y., Norimatsu, S., Ogimoto, A., Ohtsuka, T., Okayama, H., & Higaki, J. (2009) · Hypertension Research · doi:10.1038/hr.2009.41 · Cited by 28
Wu, J., & Zhou, Z. (2013) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2013.75 · Cited by 28
de Heredia, F. P., Larqué, E., Portillo, M. P., Canteras, M., Zamora, S., & Garaulet, M. (2008) · Nutrition · doi:10.1016/j.nut.2008.03.022 · Cited by 28
Sherar, L. B., Eisenmann, J. C., Chilibeck, P. D., Muhajarine, N., Martin, S., Bailey, D. A., & Baxter-Jones, A. D. G. (2011) · Obesity · doi:10.1038/oby.2010.340 · Cited by 28
Aulie, H. A., Selvaag, A. M., Günther, A., Lilleby, V., Molberg, Ø., Hartmann, A., Holdaas, H., & Flatø, B. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204804 · Cited by 28
Ding, Y., Li, S., Ma, R., Guo, H., Zhang, J., Zhang, M., Liu, J., & Guo, S. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.02.005 · Cited by 28
Determinants of VLDL composition and apo B-containing particles in familial combined hyperlipidemia
Cruz‐Bautista, I., Mehta, R., Cabiedes, J., García-Ulloa, A. C., Guillén-Pineda, L. E., Almeda‐Valdés, P., Ramos, D. C., & Aguilar-Salinas, C. A. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.018 · Cited by 28
Bhatt, S. P., Nigam, P., Misra, A., Guleria, R., Luthra, K., Pandey, R. M., & Pasha, M. A. Q. (2012) · Gene · doi:10.1016/j.gene.2012.09.067 · Cited by 28
Validation of a New Physical Activity Questionnaire for a Sedentary Population
Rubenstein, J. H., Morgenstern, H., Kellenberg, J. E., Kalish, T., Donovan, J., Inadomi, J. M., McConnell, D. S., Stojanovska, J., & Schoenfeld, P. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1641-y · Cited by 29
Caspar‐Bauguil, S., Fioroni, A., Galinier, A., Allenbach, S., Pujol, M., Salvayre, R., Cartier, A., Lemieux, I., Richard, D., Biron, S., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0633-0 · Cited by 28
Ashraf, A. P., Alvarez, J. A., Dudenbostel, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114689 · Cited by 28
Plasma and tissue homoarginine concentrations in healthy and obese humans
May, M., Kayacelebi, A. A., Bátkai, S., Jordan, J., Tsikas, D., & Engeli, S. (2015) · Amino Acids · doi:10.1007/s00726-015-1922-4 · Cited by 27
Motta, K., Barbosa, A. M., Bobinski, F., Boschero, A. C., & Rafacho, A. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.09.024 · Cited by 27
The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis C
Goossens, N., & Negro, F. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.007 · Cited by 28
Bentley–Lewis, R., Xiong, G. X., Lee, H., Yang, A., Huynh, J., & KIM, C. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.03.003 · Cited by 29
Tanabe, M., Akehi, Y., Nomiyama, T., Murakami, J., & Yanase, T. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0313 · Cited by 28
Barbato, K. B. G., Martins, R. D. C. V., Rodrigues, M. D. L. G., Braga, J. U., Francischetti, E. A., & Genelhu, V. A. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001400003 · Cited by 38
Boothby, M., McGee, K. C., Tomlinson, J., Gathercole, L., McTernan, P. G., Shojaee‐Moradie, F., Umpleby, A. M., Nightingale, P., & Shahmanesh, M. (2009) · Antiviral Therapy · doi:10.3851/imp1457 · Cited by 30
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women
Faloia, E., Tirabassi, G., Canibus, P., & Boscaro, M. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.02.004 · Cited by 28
Tisato, V., Toffoli, B., Monasta, L., et al. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.07.003 · Cited by 28
Tan, Y., Lao, W., Xiao, L., Wang, Z., Xiao, W., Kamal, M. A., Seale, J. P., & Qu, X. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/306738 · Cited by 28
Vyssoulis, G. P., Pietri, P. G., Karpanou, E. A., Vlachopoulos, C. V., Kyvelou, S.-M., Spanos, P. G., Cokkinos, D. V., & Stefanadis, C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.08.005 · Cited by 28
Failing beta-cell adaptation in South Asian families with a high risk of type 2 diabetes
Jainandunsing, S., Özcan, B., Rietveld, T., van Miert, J. N. I., Isaacs, A. J., Langendonk, J. G., de Rooij, F. W. M., & Sijbrands, E. J. G. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0588-9 · Cited by 30
Lee, I., Fu, C., Lee, W., Liang, K., Lin, S., Wan, C., & Sheu, W. H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-18 · Cited by 29
Šimonytė, K., Olsson, T., Näslund, I., Angelhed, J., Lönn, L., Mattsson, C., & Rask, E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2472 · Cited by 28
Hamasaki, H., Yanai, H., Kakei, M., Noda, M., & Ezaki, O. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006276 · Cited by 28
Enhanced Thermic Effect of Food After Roux-en-Y Gastric Bypass Surgery
Wilms, B., Ernst, B., Schmid, S. M., Thurnheer, M., & Schultes, B. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1087 · Cited by 29
Howard, B. V., Best, L. G., Comuzzie, A. G., Ebbesson, S. O. E., Epstein, S. E., Fabsitz, R. R., Howard, W. J., Silverman, A., Wang, H., Zhu, J., et al. (2008) · Diabetes Care · doi:10.2337/dc08-0815 · Cited by 28
Mirzaei, K., Hossein‐Nezhad, A., Keshavarz, S. A., et al. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-79 · Cited by 28
Biomarker and imaging responses to spironolactone in subclinical diabetic cardiomyopathy
Jellis, C. L., Sacre, J. W., Wright, J., Jenkins, C., Haluska, B. A., Jeffriess, L., Martin, J. H., & Marwick, T. H. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu013 · Cited by 28
de Rooij, S. R., Dekker, J. M., Kozàkovà, M., Mitrakou, A., Melander, O., Gabriel, R., Guidone, C., Højlund, K., Murphy, M. S., Nijpels, G., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0058 · Cited by 26
Daka, B., Rosén, T., Jansson, P. A., Larsson, C., Råstam, L., & Lindblad, U. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-30 · Cited by 28
Central adiposity and left ventricular mass in obese children
Bonito, P. D., Capaldo, B., Forziato, C., Sanguigno, E., Fraia, T. D., Scilla, C., Cavuto, L., Saitta, F., Sibilio, G., & Moio, N. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.09.002 · Cited by 28
O’Brien, D. M., Kristal, A. R., Nash, S. H., Hopkins, S. E., Luick, B. R., Stanhope, K. L., Havel, P. J., & Boyer, B. B. (2014) · Journal of Nutrition · doi:10.3945/jn.113.189381 · Cited by 28
Cordyceps militarisalleviates non-alcoholic fatty liver disease in ob/ob mice
Choi, H., Jang, Y.-H., Kim, M., Seo, M. J., Kang, B. W., Jeong, Y. K., & Kim, J.-I. (2014) · Nutrition Research and Practice · doi:10.4162/nrp.2014.8.1.172 · Cited by 28
Lundström, A., Laska, A. C., von Arbin, M., et al. (2013) · Platelets · doi:10.3109/09537104.2013.777951 · Cited by 28
Mabchour, A. E., Delisle, H. F., Vilgrain, C., Larco, P., Sodjinou, R., & Batal, M. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s88893 · Cited by 28
Hwang, Y., Hayashi, T., Fujimoto, W. Y., Kahn, S. E., Leonetti, D. L., McNeely, M. J., & Boyko, E. J. (2015) · Diabetes Care · doi:10.2337/dc15-0625 · Cited by 29
Zhang, X., Wang, Y., Zhong, M., Liu, T., Han, H., Zhang, G., Liu, S., Wei, M., Wu, Q., & Hu, S. (2015) · Obesity Surgery · doi:10.1007/s11695-015-2031-x · Cited by 27
Ishiba, H., Sumida, Y., Kataoka, S., Kuroda, M., Akabame, S., Tomiyasu, K.-I., Tanaka, M., Arai, M., Taketani, H., Seko, Y., et al. (2016) · Hepatology Research · doi:10.1111/hepr.12665 · Cited by 28
Kuo, P., Kao, C., Chen, P., Chen, C.-H., Tsai, Y.-S., Lu, M., & Huang, M. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318234ee84 · Cited by 29
Conti, F., Vukotic, R., Foschi, F. G., Domenicali, M., Giacomoni, P., Savini, S., Lanzi, A., Dall’Aglio, A. C., Saini, G., Matroroberto, M., et al. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.07.020 · Cited by 28
Velija-Ašimi, Z., Bureković, A., Dujić, T., Dizdarević-Bostandžić, A., & Semiz, S. (2016) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2016.1428 · Cited by 26
Madjd, A., Taylor, M. A., Neek, L. S., Delavari, A., Malekzadeh, R., Macdonald, I. A., & Farshchi, H. R. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.136408 · Cited by 31
Lee, D. Y., Yang, H., Kim, H. W., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.11.039 · Cited by 28
Dirajlal‐Fargo, S., Musiime, V., Cook, A. D., Mirembe, G., Kenny, J. M., Jiang, Y., Debanne, S. M., Klein, N. J., & McComsey, G. A. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001544 · Cited by 28
Trzépizur, W., Khalyfa, A., Qiao, Z., Popko, B., & Gozal, D. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.026 · Cited by 28
Serum levels of the adipomyokine irisin in patients with chronic kidney disease
Rodríguez–Carmona, A., Fontán, M. P., Sangiao‐Alvarellos, S., Falcón, T. G., Bello, M. L. P., Muñíz, A. L., & Cordido, F. (2016) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2016.11.011 · Cited by 28
Rastogi, D., Jung, M., Strizich, G., Shaw, P. A., Thomas, S., Klein, O. L., Penedo, F. J., Ries, A. L., Daviglus, M. L., Moreiras, J. J., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.03.003 · Cited by 28
Mulya, A., Haus, J. M., Solomon, T. P. J., Kelly, K. R., Malin, S. K., Rocco, M. B., Barkoukis, H. D., & Kirwan, J. P. (2017) · Obesity · doi:10.1002/oby.21799 · Cited by 28
Guadalupe‐Grau, A., Fernández-Elías, V. E., ORTEGA, J. F., Dela, F., Helge, J. W., & Mora‐Rodríguez, R. (2017) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.12881 · Cited by 30
Lee, K. S., Lee, J. K., & Yeun, Y. R. (2017) · Medical Science Monitor · doi:10.12659/msm.900515 · Cited by 28
Akl, M. G., Fawzy, E., Deif, M. M., Farouk, A., & Elshorbagy, A. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177268 · Cited by 28
Yoon, J. W., Jung, C.-H., Kim, M.-K., Park, H. E., Park, K. S., Jang, H. C., Moon, M. K., Choi, S., & Koo, B. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178741 · Cited by 29
HIV-positive youth who are perinatally infected have impaired endothelial function
Dirajlal‐Fargo, S., Sattar, A., Kulkarni, M., Bowman, E., Funderburg, N., & McComsey, G. A. (2017) · AIDS · doi:10.1097/qad.0000000000001556 · Cited by 28
Yeh, C.-W., Liu, H., Lin, L.-C., Liou, K.-T., Huang, Y., Lin, C., Tzeng, T.-T., Shie, F., Tsay, H.-J., & Shiao, Y. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.07.036 · Cited by 28
Álvarez, C., Ramírez‐Vélez, R., Ramírez‐Vélez, R., Martínez‐Salazar, C., Castro‐Sepúlveda, M., Alonso-Martínez, A. M., & Izquierdo, M. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.177 · Cited by 30
DNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy
Houshmand‐Oeregaard, A. S., Hjort, L., Kelstrup, L., Hansen, N. S., Broholm, C., Gillberg, L., Clausen, T. D., Mathiesen, E. R., Damm, P., & Vaag, A. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187038 · Cited by 29
Hua, X., Li, M., Pan, F., Xiao, Y., Cui, W., & Hu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-15232-9 · Cited by 28
Karras, S. Ν., Anagnostis, P. G., Antonopoulou, V., et al. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164117738443 · Cited by 28
Zhang, K., Chen, Y., Liu, L., Lu, M., Cheng, J., Gao, F., Wang, N., Shen, Z., & Lu, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-16108-8 · Cited by 28
Miya, A., Nakamura, A., Miyoshi, H., Takano, Y., Sunagoya, K., Hayasaka, K., Shimizu, C., Terauchi, Y., & Atsumi, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00081 · Cited by 28
Benatti, F. B., Miyake, C. N. H., Dantas, W. S., Zambelli, V. O., Shinjo, S. K., Pereira, R. M. R., Silva, M. E. R., de Sá‐Pinto, A. L., Borba, E. F., Bonfá, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00906 · Cited by 30
Lentferink, Y. E., van der Aa, M. P., van Mill, E. G. A. H., Knibbe, C. A. J., & van der Vorst, M. M. J. (2018) · Nutrition and Diabetes · doi:10.1038/s41387-018-0057-6 · Cited by 31
Rogers-Soeder, T. S., Lane, N. E., Walimbe, M., Schwartz, A. V., Tolstykh, I. V., Felson, D. T., Lewis, C. E., Segal, N. A., & Nevitt, M. C. (2018) · Arthritis Care & Research · doi:10.1002/acr.23809 · Cited by 28
Orhan, C., Küçük, O., Tuzcu, M., Şahin, N., Komorowski, J. R., & Şahin, K. (2018) · Food Science & Nutrition · doi:10.1002/fsn3.851 · Cited by 30
Duncan, A., Peters, B. S., Rivas, C. A., & Goff, L. M. (2019) · Diabetic Medicine · doi:10.1111/dme.13927 · Cited by 31
Jonas, K., Magoń, W., Podolec, P. S., & Kopeć, G. (2019) · Medical Science Monitor · doi:10.12659/msm.912766 · Cited by 29
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
